A-shares Trend | Shanghai Composite Index closes up 1.5%, returning to the 3900 level

SighingCashier · 2026-04-01T07:49:31+00:00

On the first day of April, the Shanghai Composite Index in the A-share market rebounded above 3,900 points, rising over 1% intraday. The Shanghai Composite closed at 3,948 points, up 56 points; the Shenzhen Component Index closed at 13,706 points, up 228 points. The total trading volume reached 2.01 trillion yuan. Different sectors showed mixed performance, with medical devices and biopharmaceutical stocks rising significantly, while power and oil stocks performed weakly.

SighingCashier

2026-04-01 07:49:31

Abstract generation in progress

A-shares rose more than 1% on the first day of April, and the Shanghai Composite Index returned above the 3,900-point threshold. Total trading volume on both markets increased to 2.01 trillion yuan (RMB, the same below).

The Shanghai Composite Index opened higher by 47 points, regained the 3,900-point level, and the market maintained its upward trend, rising as much as 64 points or 1.65%, hitting a high of 3,955. It closed the day at 3,948 points, up 56 points or 1.46%, with turnover of 897.278 billion yuan.

The Shenzhen Component Index opened higher and moved upward steadily, rising as much as 262 points or 1.95%, reaching a high of 13,740. It closed the day at 13,706 points, up 228 points or 1.7%, with turnover of 1.115173 trillion yuan.

The CSI 300 Index was at 4,526 points, up 76 points or 1.71%; the ChiNext Index was at 3,247 points, up 62 points or 1.96%.

Individual sectors saw mixed performance. Medical device stocks rose 4%; biopharmaceutical stocks rose more than 3%; auto manufacturing, non-ferrous metals, media and entertainment, cement, steel, and financial stocks rose more than 1%; chemical and real estate stocks held steady; power stocks fell more than 1%; oil and coal stocks were slightly weaker.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes